Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 421

1.

Effects of Ankaferd Blood Stopper and calcium alginate in experimental model of hepatic parenchymal bleeding.

Aydin O, Tuncal S, Kilicoglu B, Onalan AK, Gonultas MA, Ozer H, Durhan A, Tasova V, Hucumenoglu S, Kismet K.

Bratisl Lek Listy. 2015;116(2):128-31.

PMID:
25665481
2.

Genome-wide association study identifies susceptibility loci in IL6, RPS9/LILRB3, and an intergenic locus on chromosome 21q22 in Takayasu's arteritis.

Renauer P, Saruhan-Direskeneli G, Coit P, Adler A, Aksu K, Keser G, Alibaz-Oner F, Aydin SZ, Kamali S, Inanc M, Carette S, Cuthbertson D, Hoffman GS, Akar S, Onen F, Akkoc N, Khalidi NA, Koening C, Karadag O, Kiraz S, Langford CA, Maksimowicz-McKinnon K, McAlear CA, Ozbalkan Z, Ates A, Karaaslan Y, Duzgun N, Monach PA, Ozer HT, Erken E, Ozturk MA, Yazici A, Cefle A, Onat AM, Kisacik B, Pagnoux C, Kasifoglu T, Seyahi E, Fresko I, Seo P, Sreih A, Warrington KJ, Ytterberg SR, Cobankara V, Cunninghame-Graham DS, Vyse TJ, Pamuk ON, Tunc E, Dalkilic E, Bicakcigil M, Yentur SP, Wren JD, Merkel PA, Direskeneli H, Sawalha AH.

Arthritis Rheumatol. 2015 Jan 20. doi: 10.1002/art.39035. [Epub ahead of print]

PMID:
25604533
3.

Mass spectrometry identification of potential mediators of progestin-only contraceptive-induced abnormal uterine bleeding in human endometrial stromal cells.

Shapiro JP, Basar M, Kayisli UA, Guzeloglu-Kayisli O, Joseph Huang S, Suarez AA, Ozer HG, Schatz F, Lockwood CJ.

Contraception. 2015 Mar;91(3):253-60. doi: 10.1016/j.contraception.2014.11.005. Epub 2014 Nov 21.

4.

Role of ChIP-seq in the discovery of transcription factor binding sites, differential gene regulation mechanism, epigenetic marks and beyond.

Mundade R, Ozer HG, Wei H, Prabhu L, Lu T.

Cell Cycle. 2014;13(18):2847-52. doi: 10.4161/15384101.2014.949201.

PMID:
25486472
5.

TDS exposure project: application of the analytic hierarchy process for the prioritization of substances to be analyzed in a total diet study.

Papadopoulos A, Sioen I, Cubadda F, Ozer H, Basegmez HI, Turrini A, Lopez Esteban MT, Fernandez San Juan PM, Sokolić-Mihalak D, Jurkovic M, De Henauw S, Aureli F, Vin K, Sirot V.

Food Chem Toxicol. 2015 Feb;76:46-53. doi: 10.1016/j.fct.2014.11.015. Epub 2014 Dec 2.

PMID:
25478735
6.

Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.

Cherry M, Khawandanah M, Zhao ZJ, Srour S, Ozer H, Selby G, Ghabache B, Al-Kali A.

Ann Hematol. 2015 Apr;94(4):717-9. doi: 10.1007/s00277-014-2247-1. Epub 2014 Nov 9. No abstract available.

PMID:
25380996
7.

TDS exposure project: relevance of the total diet study approach for different groups of substances.

Vin K, Papadopoulos A, Cubadda F, Aureli F, Oktay Basegmez HI, D'Amato M, De Coster S, D'Evoli L, López Esteban MT, Jurkovic M, Lucarini M, Ozer H, Fernández San Juan PM, Sioen I, Sokolic D, Turrini A, Sirot V.

Food Chem Toxicol. 2014 Nov;73:21-34. doi: 10.1016/j.fct.2014.07.035. Epub 2014 Aug 12.

PMID:
25106751
8.

miR-let-7f-1 regulates SPARC mediated cisplatin resistance in medulloblastoma cells.

Pannuru P, Dontula R, Khan AA, Herbert E, Ozer H, Chetty C, Lakka SS.

Cell Signal. 2014 Oct;26(10):2193-201. doi: 10.1016/j.cellsig.2014.06.014. Epub 2014 Jul 8.

PMID:
25014664
9.

Costs of care for lung and colon cancer patients receiving chemotherapy following FDA policy changes.

Stroupe KT, Tarlov E, Weichle TW, Zhang QL, Michaelis LC, Ozer H, Durazo-Arvizu R, Hynes DM.

Support Care Cancer. 2014 Dec;22(12):3153-63. doi: 10.1007/s00520-014-2296-y. Epub 2014 Jun 10.

PMID:
24912857
10.

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.

Woyach JA, Furman RR, Liu TM, Ozer HG, Zapatka M, Ruppert AS, Xue L, Li DH, Steggerda SM, Versele M, Dave SS, Zhang J, Yilmaz AS, Jaglowski SM, Blum KA, Lozanski A, Lozanski G, James DF, Barrientos JC, Lichter P, Stilgenbauer S, Buggy JJ, Chang BY, Johnson AJ, Byrd JC.

N Engl J Med. 2014 Jun 12;370(24):2286-94. doi: 10.1056/NEJMoa1400029. Epub 2014 May 28.

11.

[Chordoid Meningioma - A Case Report: Clinicopathological Features and Differential Diagnosis of an Uncommon Tumor.]

Ozer H, Tuncer E, Saray G, Gürelık M, Oztoprak I, Eğılmez R.

Turk Patoloji Derg. 2014 Apr 9. doi: 10.5146/tjpath.2013.01209. [Epub ahead of print] Turkish.

12.

A novel recessive 15-hydroxyprostaglandin dehydrogenase mutation in a family with primary hypertrophic osteoarthropathy.

Erken E, Köroğlu Ç, Yıldız F, Özer HT, Gülek B, Tolun A.

Mod Rheumatol. 2015 Mar;25(2):315-21. doi: 10.3109/14397595.2013.874757. Epub 2014 Feb 18.

PMID:
24533558
13.

Identification of medium-sized copy number alterations in whole-genome sequencing.

Ozer HG, Usubalieva A, Dorrance A, Yilmaz AS, Caligiuri M, Marcucci G, Huang K.

Cancer Inform. 2015 Mar 5;13(Suppl 3):105-11. doi: 10.4137/CIN.S14023. eCollection 2014.

14.

A case of an idiopathic massive osteolysis with skip lesions.

Ozbayrak M, Yilmaz MH, Kantarci F, Ozer H, Harmanci K, Babacan M, Dervisoglu S.

Korean J Radiol. 2013 Nov-Dec;14(6):946-50. doi: 10.3348/kjr.2013.14.6.946. Epub 2013 Nov 5.

15.

MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling.

Dontula R, Dinasarapu A, Chetty C, Pannuru P, Herbert E, Ozer H, Lakka SS.

Genes Cancer. 2013 Jul;4(7-8):285-96. doi: 10.1177/1947601913500141.

16.

A huge duplication cyst of the ileum.

Atalar MH, Cankorkmaz L, Ozer H, Koyluoglu G.

Pol J Radiol. 2013 Jul;78(3):70-3. doi: 10.12659/PJR.884012.

17.

Ubiquitin-mediated interaction of p210 BCR/ABL with β-catenin supports disease progression in a murine model for chronic myelogenous leukemia.

Chen R, Hu T, Mahon GM, Tala I, Pannucci NL, Ozer HL, Whitehead IP.

Blood. 2013 Sep 19;122(12):2114-24. doi: 10.1182/blood-2013-01-481184. Epub 2013 Aug 15.

18.

Identification of multiple genetic susceptibility loci in Takayasu arteritis.

Saruhan-Direskeneli G, Hughes T, Aksu K, Keser G, Coit P, Aydin SZ, Alibaz-Oner F, Kamalı S, Inanc M, Carette S, Hoffman GS, Akar S, Onen F, Akkoc N, Khalidi NA, Koening C, Karadag O, Kiraz S, Langford CA, McAlear CA, Ozbalkan Z, Ates A, Karaaslan Y, Maksimowicz-McKinnon K, Monach PA, Ozer HT, Seyahi E, Fresko I, Cefle A, Seo P, Warrington KJ, Ozturk MA, Ytterberg SR, Cobankara V, Onat AM, Guthridge JM, James JA, Tunc E, Duzgun N, Bıcakcıgil M, Yentür SP, Merkel PA, Direskeneli H, Sawalha AH.

Am J Hum Genet. 2013 Aug 8;93(2):298-305. doi: 10.1016/j.ajhg.2013.05.026. Epub 2013 Jul 3.

19.

Clinicopathological determinants of positron emission tomography computed tomography fluorodeoxyglucose standardised uptake value in head and neck carcinoma.

Ozer E, Naiboglu B, Karapinar U, Agrawal A, Ozer HG, Schuller DE.

J Laryngol Otol. 2013 Jul;127(7):676-80. doi: 10.1017/S002221511300128X. Epub 2013 Jun 21.

PMID:
23790108
20.

Intensive care unit versus non-intensive care unit postoperative management of head and neck free flaps: comparative effectiveness and cost comparisons.

Arshad H, Ozer HG, Thatcher A, Old M, Ozer E, Agarwal A, Jafari H, Birkheimer D, Basinger H, Forest LA, Schuller DE, Teknos TN.

Head Neck. 2014 Apr;36(4):536-9. doi: 10.1002/hed.23325. Epub 2013 Jun 18.

PMID:
23780531
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk